13F COMBINATION REPORT
DC Funds, LP
Quarter ended Q3 2025 · Filed November 10, 2025 · Accession 0001398344-25-020563
Total Value
$3.1M
Positions
3
Other Managers
0
Confidential Omitted
No
Holdings (3)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | WEREWOLF THERAPEUTICS INC | HOWL | 589,102 | $1.2M | 37.32% |
| 2 | TSCAN THERAPEUTICS INC | TCRX | 630,000 | $1.1M | 36.87% |
| 3 | BARINTHUS BIOTHERAPEUTICS PL | BRNS | 642,204 | $802,755 | 25.81% |